142 related articles for article (PubMed ID: 22526310)
1. Modeling approach to characterize intraocular doripenem pharmacokinetics after intravenous administration to rabbits, with tentative extrapolation to humans.
Semoun O; Marchand S; Grégoire N; Lamarche I; Adier C; Laroche L; Goldschmidt P; Couet W
Antimicrob Agents Chemother; 2012 Jul; 56(7):3531-4. PubMed ID: 22526310
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue penetration of a new carbapenem, doripenem, intravenously administered to laboratory animals.
Hori T; Nakano M; Kimura Y; Murakami K
In Vivo; 2006; 20(1):91-6. PubMed ID: 16433034
[TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetic Analysis of Doripenem after Intravenous Infusion in Korean Patients with Acute Infections.
Lee DH; Kim YK; Jin K; Kang MJ; Joo YD; Kim YW; Moon YS; Shin JG; Kiem S
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223378
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients.
Samtani MN; Flamm R; Kaniga K; Nandy P
Antimicrob Agents Chemother; 2010 Jun; 54(6):2360-4. PubMed ID: 20385857
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic-pharmacodynamic target attainment analysis of doripenem in infected patients.
Ikawa K; Morikawa N; Uehara S; Monden K; Yamada Y; Honda N; Kumon H
Int J Antimicrob Agents; 2009 Mar; 33(3):276-9. PubMed ID: 19095418
[TBL] [Abstract][Full Text] [Related]
6. [Measurement and the clinical significance for the intraocular concentrations of carboplatin after systemic and local administration in rabbits].
Mao Y; Wu Z; Lin S; Li W
Yan Ke Xue Bao; 2004 Jul; 20(2):123-6. PubMed ID: 15301112
[TBL] [Abstract][Full Text] [Related]
7. Measurement of intraocular concentrations of etoposide after systemic and local administration.
Mao Y; Wu Z; Yang H; Lin S; Zheng J
Yan Ke Xue Bao; 2004 Sep; 20(3):178-80, 186. PubMed ID: 15499727
[TBL] [Abstract][Full Text] [Related]
8. [Analysis on the effective dosage regimens for meropenem, biapenem and doripenem against P. aeruginosa infection based on pharmacokinetics and pharmacodynamics theory].
Sumitani Y; Kobayashi Y
Jpn J Antibiot; 2007 Dec; 60(6):394-403. PubMed ID: 18447209
[TBL] [Abstract][Full Text] [Related]
9. Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits.
Miller MH; Madu A; Samathanam G; Rush D; Madu CN; Mathisson K; Mayers M
Antimicrob Agents Chemother; 1992 Jan; 36(1):32-8. PubMed ID: 1590696
[TBL] [Abstract][Full Text] [Related]
10. Effect of ocular compression on intraocular penetration of systemic ofloxacin.
Ugurbas SH; Can M; Koksal M; Dincel A; Bozkurt A; Bayar B
Adv Ther; 2007; 24(2):394-401. PubMed ID: 17565931
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of single-dose doripenem in adults with cystic fibrosis.
Cirillo I; Vaccaro N; Redman R; Black PL; Kearns GL
J Clin Pharmacol; 2012 Nov; 52(11):1645-53. PubMed ID: 22174436
[TBL] [Abstract][Full Text] [Related]
12. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J
J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic analysis of doripenem in elderly patients with nosocomial pneumonia.
Harada M; Inui N; Suda T; Nakamura Y; Wajima T; Matsuo Y; Chida K
Int J Antimicrob Agents; 2013 Aug; 42(2):149-54. PubMed ID: 23684002
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of puerarin in the aqueous humor and vitreous of rabbit eye following systemic administration].
Deng X; Zhang Q; Hu S; Gao Y; Yan L
Yan Ke Xue Bao; 2006 Dec; 22(4):275-9. PubMed ID: 17378162
[TBL] [Abstract][Full Text] [Related]
15. Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age.
Cirillo I; Vaccaro N; Castaneda-Ruiz B; Redman R; Cossey V; Bradley JS; Allegaert K
Antimicrob Agents Chemother; 2015 Aug; 59(8):4742-9. PubMed ID: 26014957
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of doripenem during high volume hemodiafiltration in patients with septic shock.
Tamme K; Oselin K; Kipper K; Low K; Standing JF; Metsvaht T; Karjagin J; Herodes K; Kern H; Starkopf J
J Clin Pharmacol; 2015 Apr; 55(4):438-46. PubMed ID: 25408310
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey.
Savinainen A; Prusakiewicz JJ; Oswald J; Spencer E; Lou Z; Cohen ML; Rashidzadeh H; Josiah S
Exp Eye Res; 2019 Dec; 189():107836. PubMed ID: 31626797
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, safety, and tolerability of doripenem after 0.5-, 1-, and 4-hour infusions in healthy volunteers.
Cirillo I; Vaccaro N; Turner K; Solanki B; Natarajan J; Redman R
J Clin Pharmacol; 2009 Jul; 49(7):798-806. PubMed ID: 19553404
[TBL] [Abstract][Full Text] [Related]
19. Penetration and decay of meropenem into the human aqueous humor and vitreous.
Schauersberger J; Amon M; Wedrich A; Nepp J; El Menyawi I; Derbolav A; Graninger W
J Ocul Pharmacol Ther; 1999 Oct; 15(5):439-45. PubMed ID: 10530705
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and monte carlo simulations of doripenem in patients with febrile neutropenia.
Stein GE; Kulhanek G; Smith CL; Kuti JL; Nicolau DP; Scharmen A; Farnum C; Tran M; Kalra A; Havlichek DH
Ann Pharmacother; 2012 Oct; 46(10):1281-6. PubMed ID: 23012385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
